Skip to main navigation Skip to search Skip to main content

Michaelis-menten cytometry for the evaluation of chronic myelogenous Leukemia (CML) at single-cell resolution

  • Stony Brook University

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

We developed a cytometry array that measures the activity of the BCR-ABL pathway in single-cells by exploiting Michaelis-Menten kinetics. BCR-ABL is a constitutively activated kinase responsible for Chronic Myelogenous Leukemia (CML) [1]. Our goal is to test the role of the highly BCR-ABL expressing clones in the drug resistance of CML. We detect the phosphorylation of CrkL, an effector of BCR-ABL, in single-cells via enzymatic amplification within an array of sealed microwells. Using the platform, we characterized the level of BCR-ABL activation in several cell lines using real-time data and advanced data analysis.

Original languageEnglish
Title of host publication23rd International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2019
PublisherChemical and Biological Microsystems Society
Pages482-483
Number of pages2
ISBN (Electronic)9781733419000
StatePublished - 2019
Event23rd International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2019 - Basel, Switzerland
Duration: Oct 27 2019Oct 31 2019

Publication series

Name23rd International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2019

Conference

Conference23rd International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2019
Country/TerritorySwitzerland
CityBasel
Period10/27/1910/31/19

Keywords

  • Array of microwells
  • Enzymatic amplification
  • Michaelis-Menten kinetics
  • Single-cell analysis

Fingerprint

Dive into the research topics of 'Michaelis-menten cytometry for the evaluation of chronic myelogenous Leukemia (CML) at single-cell resolution'. Together they form a unique fingerprint.

Cite this